Gastric infarction is rare, owing to the extensive collateral circulation of the stomach. A case of gastric infarction occurring in a patient with septic shock secondary to pneumonia is presented. The aetiology, diagnosis and therapy of gastric infarction are discussed, with consideration of the role of sepsis and vasopressors in pathogenesis and the concept of splanchnic resuscitation in prevention of the condition.
Septic shock produces profound changes in the splanchnic circulation, rendering the gut susceptible to ischaemia. Although in sepsis there is an increase in blood flow this is outweighed by an increase in O 2 demand, indicating a risk of splanchnic hypoxia 1 . There may also be (overt or covert) myocardial dysfunction, hypoxia or hypovolaemia that further reduce splanchnic oxygen delivery as blood is redistributed to the cerebral and coronary circulations 2 . Treatment of the shock state, including mechanical ventilation and the use of vasoactive agents, may serve to exacerbate these changes by further altering regional blood flow.
Therefore, in critical illness there is an appreciable incidence of mesenteric ischaemia 3 , usually affecting the small and large intestines owing to the relative lack of arterial anastomoses 4 . The gastric circulation, however, has extensive anastomoses at arterial and arteriolar level 4 affording a degree of protection against ischaemia and infarction. Furthermore, under certain conditions, gastric blood flow may increase while small intestinal blood flow decreases as a sideeffect of the hepatic arterial buffer response 5 . Infarction of the stomach is therefore rare.
CASE REPORT
A 67-year-old man with a background of severe asthma complicated by allergic bronchpulmonary aspergillosis and bronchiectasis presented to the Emergency Department with a history of five days of cough and shortness of breath and one day of chest pain and increasing wheeze. On examination he was tachypnoeic, tachycardic and cyanosed, with bibasal crepitations and wheeze throughout both lung fields. Initial investigations showed a creatinine of 0.24 mmol.l -1 , white cell count of 20.3x10.9.l -1 , arterial pH of 7.29 with a lactate of 9.9 mmol.l -1 , and PO 2 56 mmHg with PCO 2 23 mmHg on room air. Other blood tests were within normal limits. Chest X-ray showed a right lower zone infiltrate. A diagnosis of lower respiratory tract infection was made and treatment with ceftriaxone, hydrocortisone and continuous positive airway pressure (CPAP) was started.
Within two hours his condition had deteriorated with increasing metabolic acidosis and a fall in his Glasgow Coma Score (GCS) from 15 to 7. Tracheal intubation and positive pressure ventilation was necessary. He became hypotensive, with a mean arterial pressure (MAP) of 40 mmHg despite fluid resuscitation and a noradrenaline infusion was started. He was transferred to the Intensive Care Unit (ICU) where continuous venovenous haemodiafiltration (CVVHDF) was started to correct severe persistent lactic acidosis (pH 7.0 and lactate of 12 mmol.l -1 ) in the face of oliguria and an elevated creatinine. Anticoagulation with heparin and lactate-free dialysate were used. During attempts to start renal support the MAP dropped to less than 30 mmHg on two separate occasions and increasing doses of norepinephrine (up to 100 µg.min -1 ) were needed. Vasopressin at 0.02 units per minute (U.min -1 ) was started, and the MAP stabilized at 65 mmHg.
Over the next forty-eight hours he remained intubated and ventilated with acceptable oxygenation and normocapnia with positive end expiratory pressure (PEEP) of 10 cmH 2 O and fractional inspired oxygen concentration (FiO 2 ) of 0.4. Haemodynamic support was reduced slightly with noradrenaline at 20 µg.min -1 and vasopressin at 0.02 U.min -1 required to maintain a MAP of 65 mmHg. Renal support continued with full anticoagulation and lactate-free dialysate, but despite these measures the arterial pH remained low (between 7.15 and 7.25) and the lactate high (between 9 and 12 mmol.l -1 ). The liver function tests (which had been within normal limits on admission) were noted to be elevated, with ALT of 5390 U.l -1 and alkaline phosphatase of 218 U.l -1 . During this time he suffered two episodes of hypoglycaemia that resolved with a 10% dextrose infusion.
Subsequent to this nasogastric feeds were started on the second day in ICU and were initially well tolerated. Ceftriaxone (1 g daily) and hydrocortisone (100 mg four times daily) were continued.
Overnight on the second day of admission the patient developed atrial fibrillation with a ventricular response rate of 60 to 70 beats per minute and haemodynamic compromise (with the MAP falling to 50 mmHg). Cardioversion was not successful and no other anti-arrhythmic therapy was given. Vasopressor requirements again increased with noraderenaline up to 35 µg.min -1 and vasopressin unchanged at 0.02 U.min -1 . Early on day 3 a distended abdomen was noted, and nasogastric aspirates climbed rapidly to 500ml every four hours of what appeared to be blood. A surgical consult and computed tomography (CT) of the abdomen were arranged. The abdominal CT showed a dilated stomach with gas in the stomach wall as well as within the portal system and liver, and partial small bowel obstruction at the jejunal level. A diagnosis of gastric infarction was made. Given the severity of the patient's current and previous illness it was decided with the agreement of the family not to proceed to total gastrectomy, and haemodynamic and renal support was withdrawn.
The patient died four hours after the withdrawal of active management. Pseudomonas aeruginosa was subsequently grown from sputum specimens obtained on admission. A post mortem examination was not performed.
DISCUSSION
Gastric infarction is rare, yet may complicate a range of congenital and acquired conditions. This is the first case reported associated with sepsis and high dose vasopressor use.
The stomach has a very well developed anastamotic network with no end arteries 4 . Under experimental conditions, ligation of all four major gastric arterial trunks as well as 80% of smaller arterial branches will not produce infarction. However, ligation of the veins as well reliably results in infarction 19 . The disruption of the venous drainage of the stomach therefore appears to be a significant factor in the development of gastric infarction. Venous drainage may be occluded in several ways, for example by high intra-gastric pressure secondary to acute gastric dilatation, by venous thromboembolism, or following surgery. The pre-existence of arterial vascular disease or anatomical abnormalities may confer additional risk.
Symptoms of gastric infarction are non-specific and include abdominal pain, vomiting or haematemesis, and abdominal distension. Signs may include fever, tachycardia and hypotension, epigastric or generalized tenderness or a rigid abdomen and absent bowel sounds. However, there are no pathognomonic features of the condition and diagnosis must be made on the basis of clinical suspicion and appropriate investigations.
Laboratory tests are generally not helpful in the diagnosis of gastric infarction. The most common finding reported is a raised white cell count. Arterial lactate may be raised. Plain abdominal radiography may show a dilated stomach. Gas within the stomach wall is a late finding indicative of infarction and necrosis often with secondary infection (emphysematous gastritis 20 ) . CT of the abdomen shows a thickened stomach wall that does not enhance after the administration of contrast, and may contain gas. Alternatively the diagnosis can be made endoscopically (where necrotic gastric mucosa appears erythematous, eroded and friable) or at laparotomy. Pathological specimens will confirm necrosis and may reveal bacterial infection 20 .
Initial management of gastric infarction includes resuscitation, insertion of a nasogastric tube and administration of broad-spectrum antibiotics. Subsequent treatment of gastric infarction is surgical, and involves resection of necrotic tissue with primary 16 or delayed 10 anastomosis, a decision that may be made with the help of perioperative endoscopy 21 . Mortality from gastric infarction is high (estimated at over 80% 21 ), and approaches 100% when secondary infection is established 20 . Prompt surgical intervention may be lifesaving.
In this case the persistent lactic acidosis prompted a search for the source of the lactate. Renal replacement therapy is not a treatment for lactic acidosis (and in the face of ongoing lactate production may not reduce lactate levels), as it does not address the cause of the problem. The high lactate on admission begs the question whether the stimulus to lactate production initially was severe sepsis, or splanchnic ischaemia. The development of abnormal liver function tests on day 2 of admission suggests that the splanchnic insult occurred at the time of profound hypotension and very high-dose noradrenaline use associated with the start of CVVHDF.
Sepsis predisposes to splanchnic ischaemia primarily due to an increase in oxygen demand that exceeds any increase in regional blood flow 1 . Microvascular changes induced by mediators of sepsis (for example alteration of capillary flow or increased capillary leakage) further increase the risk of tissue hypoxia, which may persist in the splanchnic circulation despite resuscitation to conventional endpoints 22 .
Catecholamines have complex effects on splanchnic blood flow in septic patients, according to the pattern of receptor stimulation at the dose used, and the baseline cardiovascular state of the individual patient. The effect of low doses of noradrenaline in sepsis and septic shock is to increase splanchnic blood flow (related to beta-adrenergic stimulation 23 ); however, although blood flow may increase there may be no corresponding increase in oxygen utilization. As the dose is increased there is little additional increase in splanchnic flow despite higher cardiac output and mean arterial pressure; further increases (noradrenaline doses of up to 47 (±39) µg.min -1 have been studied, with one patient receiving 115 µg.min -1 ) do not lead to falls in splanchnic blood flow in septic patients 24 . However, at extreme doses, alphaadrenergic stimulation predominates and profound vasoconstriction means there is a high risk of ischaemia and infarction, a situation most often encountered clinically in the skin and extremities. This risk is greatly increased if vasoconstriction occurs in the face of hypovolaemia or myocardial dysfunction. In the case presented, the absence of cardiac output monitoring may have led to this precise situation, with an unrecognised low cardiac output contributing significantly to mesenteric ischaemia and ultimately gastric infarction.
Vasopressin also has effects that may be relevant to the development of gastric (and intestinal) ischaemia and infarction 25 . First, vasopressin produces vasoconstriction of the splanchnic vascular bed, and enhances noradrenaline-induced contraction of vascular smooth muscle even in the presence of endotoxin. Second, vasopressin can inhibit gut motility and may predispose to the development of ileus and an increase in intraluminal volume 26 . Finally, vasopressin promotes platelet activation and release of procoagulant molecules, which may increase the risk of thrombosis, especially at low blood flows. In the case discussed the dose of vasopressin used (0.02 U.min -1 ) was relatively low (doses of up to 0.04 U.min -1 are commonly used), and could have been increased in an attempt to spare high doses of catecholamines. Despite this, the exact in vivo effects of such doses on regional circulations, or on platelet activation, in septic states are not known and it should not be forgotten that vasopressin does have the potential to cause or exacerbate splanchnic ischaemia. This may be particularly true in combination with high doses of other vasopressors, and in patients with a low cardiac output state.
How and why might the risk of gastric ischaemia in particular and mesenteric ischaemia in general be reduced in sepsis? Resuscitation to conventional endpoints may not be sufficient to reverse mesenteric ischaemia 22 , so the use of monitors of regional perfusion, such as gastric tonometry, may highlight patients at increased risk. "Gut directed therapy" (or "splanchnic resuscitation") may then be used with the aim of increasing splanchnic blood flow and improving tissue oxygenation. In turn this is hypothesized to reduce gut production of cytokines and bacterial translocation that may contribute to the establishment and maintenance of multi-organ failure.
Both adrenergic and non-adrenergic agents have been used 27 , with perhaps the most encouraging and consistent results seen with dobutamine, although others, including prostacyclin, N-acetylcysteine and enoximone 28 may have promise. It is reasonable to suggest that those patients at high risk of splanchnic ischaemia (for example, those treated with high dose noradrenaline or any dose of vasopressin, such as this case) also receive a "splanchnic dose" of an inodilator such as dobutamine. This should not be regarded as a substitute for correction of hypovolaemia and optimization of myocardial function, which are essential in the treatment of any shock state. It must be noted that despite a decade of interest in gut-directed therapy, the evidence for an improvement in outcome remains suggestive at best.
In the case presented there are a number of interventions which may have reduced the risk of gastric infarction. First, given the history of bronchiectasis, the antibiotic therapy could have been broadened to cover Pseudomonas, which may have reduced the severity of the illness. Second, myocardial filling and function could have been optimized with the help of a monitor of cardiac output to allow vasopressor doses to be minimized. Third, the vasopressin dose could have been increased to 0.04 U.min -1 (considered safe in the treatment of sepsis 25 ) to allow reduction of the noradrenaline dose. However, as noted above, this may not necessarily have led to an increase in splanchnic blood flow. Finally, a splanchnic vasodilator such as dobutamine could have been used, either empirically or directed by gastric tonometry.
In conclusion, gastric infarction is a rare condition which may be the cause or a complication of ICU admission. The critically ill are susceptible to mesenteric ischaemia and infarction for several reasons, including the administration of catecholamine and non-catecholamine vasopressors. Treatment directed at improving splanchnic perfusion may prevent this complication.
